Exabis Library
Welcome to the e-CCO Library!
P028: Transitioning patients from intravenous to subcutaneous infliximab and vedolizumab for inflammatory bowel disease – what is the opportunity cost of improving access to health care?
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P029 TRIM 21 protects against ulcerative colitis and colitic cancer via smad7 inhibition
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P0290: Predicting disease remission in Ulcerative Colitis patients - early results from the PRESAGER study
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0291: Tailoring Crohn’s disease surveillance after ileocolic resection: the importance of inflammatory biomarkers
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0292: CD8+ Cell Dominance in Immune Checkpoint Inhibitor-Induced Colitis and Its Heterogeneity Across Endoscopic Features
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0293: The utility of small bowel capsule endoscopy in Crohn’s Disease – a retrospective cohort study
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0294: Functional outcomes after primary ileocecal resection for Crohn’s disease
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0295: Histological healing reduces the risk of relapse in ulcerative colitis: results of a prospective study
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0296: Comparison of clinical characteristics of Montreal classification group A3 patients with Crohn’s disease in Korea: Results from the Prospective and Retrospective CONNECT Study
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0297: Development of Red Flags Index for Crohn’s Disease in the Korean population
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0298: Revolutionizing Diagnostics: Evaluating ChatGPT-4's Performance in Ulcerative Colitis Endoscopic Assessment
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0299: Luminal phenotype of Crohn's disease: the effectiveness of ultrasound compression elastography in the early diagnosis of disease recurrence.
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P029: Activation of FXR restores expression of genes dysregulated in human IBD and suppresses TNFa and IL-6 signaling pathways in adoptive transfer colitis model
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P029: Azelnidipine, a novel calcium channel blocker, ameliorates severity of colitis in DSS induced colitis in mice possibly by modulating tissue levels of TNF-alpha and IL-6
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P029: Expression of miR-21 in mucosal biopsies give clues to anti-TNF treatment non-response in IBD children and adults
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P029: Histopathological characterization of a chronic DSS-induced mouse model of IBD with intestinal fibrosis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P029: Intestinal mesenchymal-specific IKK2 promotes initiation of colitis and colitis-associated cancer
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P029: Modulation of intestinal epithelial permeability by plasma from patients with Crohn’s disease in a 3D cell culture model
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P029: Serum bile acids profiling in IBD patients treated with anti-TNFs
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P030 Dynamics of intestinal inflammation and microbial dysbiosis in pregnant women with IBD and their infants
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM